Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
KRX:207940
Price:
999 999.9999
KRW
Market Cap:
₩82.3T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Samsung Biologics Co Ltd
KRX:207940
|
KR |
|
I
|
International Conveyors Ltd
NSE:INTLCONV
|
IN |
|
DXSTORM.com Inc
XTSX:DXX
|
CA |
|
S
|
Solar A/S
XBER:ZVR
|
DK |
|
S
|
Sub Sri Thai Real Estate Investment Trust
SET:SSTRT
|
TH |
|
Galliford Try Holdings PLC
LSE:GFRD
|
UK |
|
Ashland Global Holdings Inc
NYSE:ASH
|
US |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
CN |
|
Westport Fuel Systems Inc
TSX:WPRT
|
CA |
|
G
|
GIB Capital Group Inc
OTC:GIBX
|
US |
|
P
|
PJBumi Bhd
KLSE:PJBUMI
|
MY |
|
Shanghai Zhangjiang Hi-Tech Park Development Co Ltd
SSE:600895
|
CN |
|
V
|
Viagold Rare Earth Resources Holdings Ltd
ASX:VIA
|
AU |
|
O
|
OneForce Holdings Ltd
HKEX:1933
|
HK |
|
Bakkt Holdings Inc
NYSE:BKKT
|
US |
|
Healthcare Services Group Inc
NASDAQ:HCSG
|
US |
|
U
|
Unlu Yatirim Holding AS
IST:UNLU.E
|
TR |
|
I
|
Iskandar Waterfront City Bhd
KLSE:IWCITY
|
MY |
|
H
|
Hutchison Telecommunications Hong Kong Holdings Ltd
SWB:4C6
|
HK |
Relative Value
The Relative Value of one
Samsung Biologics Co Ltd
stock under the Base Case scenario is
hidden
KRW.
Compared to the current market price of 999 999.9999 KRW,
Samsung Biologics Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Samsung Biologics Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Samsung Biologics Co Ltd Competitors
Samsung Biologics Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
972B USD | 340.3 | 4 030 | 1 154.8 | 2 223.7 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
184.6B USD | 4.1 | 27.5 | 19.1 | 25.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
132.3B USD | 5.4 | 36.6 | 18.7 | 27.2 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
32.7B CHF | 5.1 | 35.4 | 26.4 | 26.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
268.9B CNY | 6.1 | 17.9 | 18 | 18 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.9B USD | 4.5 | 24.8 | 18.2 | 21.5 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.7B USD | 9.4 | 46.1 | 29.8 | 37.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.1B USD | 1.7 | 20.8 | 11.6 | 17.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.8B USD | 6.4 | 29.6 | 22 | 24.4 | |
| US |
|
Illumina Inc
NASDAQ:ILMN
|
19.3B USD | 4.4 | 22.7 | 17 | 22.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
